Status:
COMPLETED
The Major Bleeding Risk Following Hepatectomy
Lead Sponsor:
China Medical University Hospital
Collaborating Sponsors:
An-Nan Hospital, China Medical University
Ministry of Health and Welfare, Taiwan
Conditions:
Gastrointestinal Hemorrhage
Postoperative Hemorrhage
Eligibility:
All Genders
20+ years
Brief Summary
This study examined long-term incidence rates of major bleeding associated with hepatectomy. The investigators used data from Taiwan's National Health Insurance Research Database. Patients who underwe...
Detailed Description
The study population consisted of two cohorts. Patients who underwent hepatectomy (ICD-9-CM procedure code: 50.2, 50.22, 50.3 and 50.4) between 2000 and 2012 were identified as the surgery cohort. The...
Eligibility Criteria
Inclusion
- Patients who underwent hepatectomy between 2000 and 2012.
Exclusion
- Patients younger than 20 years of age
- Patients diagnosed with coagulation defects or had a pre-existing bleeding episode before the earliest date that patients underwent hepatectomy.
Key Trial Info
Start Date :
January 1 2000
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2018
Estimated Enrollment :
5265 Patients enrolled
Trial Details
Trial ID
NCT04748081
Start Date
January 1 2000
End Date
December 31 2018
Last Update
February 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China Medical University Hospital
Taichung, Taiwan, 404